|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 773.40 USD | +0.36% |
|
-2.23% | +0.21% |
| 05:48pm | Nektar's lead drug candidate shows promise in eczema trial, shares soar | RE |
| 04:42pm | Novo Nordisk Launches Weight Loss Drug Wegovy in India | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.36% | -2.23% | +6.67% | -10.56% | +0.21% | -13.09% | +137.57% | +392.63% | +840.41% | 692B | ||
| +0.64% | -0.18% | -0.74% | -6.85% | +5.18% | +2.01% | -16.56% | +8.79% | +53.14% | 364B | ||
| +0.65% | -0.40% | -0.53% | -11.68% | +3.96% | +6.95% | +21.27% | +94.18% | +166.89% | 325B | ||
| +0.53% | -7.16% | -1.58% | -13.16% | -27.42% | -54.16% | +15.24% | +104.51% | +140.15% | 310B | ||
| +0.61% | +0.19% | -0.15% | -13.84% | +2.58% | +2.62% | -17.79% | -21.10% | -3.14% | 257B | ||
| +0.36% | -0.16% | +1.72% | -2.75% | +7.58% | -0.61% | +18.39% | +13.04% | +0.02% | 229B | ||
| -0.84% | -3.10% | -1.00% | -9.78% | -1.30% | -17.20% | -4.12% | +23.83% | +143.11% | 218B | ||
| -0.55% | +1.33% | +2.23% | -14.07% | -20.27% | -40.34% | -14.83% | +4.55% | +36.20% | 201B | ||
| +1.99% | -4.28% | -0.64% | -11.68% | +6.53% | -12.73% | +13.16% | +19.41% | +73.65% | 146B | ||
| +0.94% | +0.85% | +2.52% | -7.40% | -8.76% | -14.65% | -53.08% | -24.81% | -29.29% | 137B | ||
| +0.73% | -0.99% | -1.98% | +0.18% | +15.76% | +51.18% | +69.51% | +40.83% | -12.36% | 132B | ||
| +0.71% | -1.40% | -9.84% | -19.46% | -10.75% | -7.41% | -16.81% | -8.13% | -9.65% | 117B | ||
| +1.25% | +1.33% | +0.42% | -12.48% | +11.22% | -5.70% | +53.10% | +53.82% | +245.61% | 114B | ||
| -0.07% | -0.66% | +0.06% | -23.14% | -17.04% | +11.11% | -40.58% | -18.77% | -29.77% | 95.49B | ||
| +0.33% | +2.04% | -0.36% | +8.87% | +7.66% | +40.63% | +111.06% | +31.58% | +425.70% | 84.43B | ||
| +0.50% | -4.73% | -2.62% | -5.05% | +4.72% | -12.34% | -35.77% | -30.99% | -18.44% | 76.69B | ||
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | ||
| +0.37% | -2.99% | -4.31% | +16.28% | +13.62% | +30.24% | +58.37% | -33.78% | +272.64% | 47.97B | ||
| -0.31% | -0.57% | -7.38% | -0.70% | +1.43% | +14.51% | - | - | - | 46.6B | ||
| +1.89% | +0.46% | +4.53% | -3.85% | +4.40% | +6.59% | +17.75% | +9.04% | -28.05% | 45.71B | ||
| Average | +0.52% | -3.08% | -0.68% | -7.43% | -0.04% | -0.65% | +17.55% | +36.59% | +125.93% | 185.12B | |
| Weighted average by Cap. | +0.47% | -4.27% | +0.71% | -9.48% | -1.37% | -7.37% | +30.86% | +97.09% | +225.91% |
- Stock Market
- Equities
- LLY Stock
- Sector Eli Lilly and Company
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition